BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18094594)

  • 1. Characteristics of acute myeloid leukemia without HLA-DR expression.
    Moon H; Lee S; Huh J; Chung WS
    Korean J Lab Med; 2007 Oct; 27(5):313-7. PubMed ID: 18094594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR antigen-negative acute myeloid leukemia.
    Wetzler M; McElwain BK; Stewart CC; Blumenson L; Mortazavi A; Ford LA; Slack JL; Barcos M; Ferrone S; Baer MR
    Leukemia; 2003 Apr; 17(4):707-15. PubMed ID: 12682628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia.
    Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C
    Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunophenotypic features in 143 cases of acute promyelocytic leukemia].
    Sun HM; Qian SX; Wu YJ; Qiao C; Hong M; Fan L; Yang H; Zhang JF; Zhang SJ; Wu HX; Qiu HX; Lu H; Xu W; Sheng RL; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):176-9. PubMed ID: 19236773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations.
    Gajendra S; Gupta R; Thakral D; Gupta SK; Jain G; Bakhshi S; Sharma A; Sahoo RK; Kumar L; Rai S; Singh S; Upadhyay AD
    Int J Lab Hematol; 2023 Apr; 45(2):221-228. PubMed ID: 36504282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
    Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
    Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.
    Iriyama N; Asou N; Miyazaki Y; Yamaguchi S; Sato S; Sakura T; Maeda T; Handa H; Takahashi M; Ohtake S; Hatta Y; Sakamaki H; Honda S; Taki T; Taniwaki M; Miyawaki S; Ohnishi K; Kobayashi Y; Naoe T
    Ann Hematol; 2014 Jun; 93(6):957-63. PubMed ID: 24441947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR; Zhu HH; Ruan GR; Qin YZ; Shi HX; Lai YY; Chang Y; Wang YZ; Lu D; Hao L; Li JL; Li LD; Jiang B; Huang XJ
    Leuk Res; 2013 Jul; 37(7):737-41. PubMed ID: 23601747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunophenotypic analysis of leukemia promyelocytes in 71 patients with acute promyelocytic leukemia].
    Liu Y; Chen YT; Li JX; Zhang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):806-11. PubMed ID: 22931633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
    Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The triple-negative (CD34-/HLA-DR-/CD11b-) profile rapidly and specifically identifies an acute promyelocytic leukemia.
    Rahman K; Gupta R; Singh MK; Sarkar MK; Gupta A; Nityanand S
    Int J Lab Hematol; 2018 Apr; 40(2):144-151. PubMed ID: 28984423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia.
    Mosleh M; Mehrpouri M; Ghaffari S; Saei Z; Agaeipoor M; Jadali F; Satlsar ES; Gholampour R
    Scand J Clin Lab Invest; 2020; 80(2):87-92. PubMed ID: 31829759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical and laboratory features of acute promyelocytic leukemia: an analysis of 513 cases].
    Liang JY; Wu DP; Liu YJ; Ma QF; Gong JX; Zhu MQ; Xue YQ; Chen ZX
    Zhonghua Nei Ke Za Zhi; 2008 May; 47(5):389-92. PubMed ID: 18953948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD9
    Ren F; Zhang N; Xu Z; Xu J; Zhang Y; Chen X; Tan Y; Chang J; Wang H
    Int J Lab Hematol; 2019 Apr; 41(2):168-175. PubMed ID: 30315692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study.
    Paietta E; Andersen J; Gallagher R; Bennett J; Yunis J; Cassileth P; Rowe J; Wiernik PH
    Leukemia; 1994 Jul; 8(7):1108-12. PubMed ID: 8035602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.